ClearPoint NeuroCLPT
Market Cap: $321M
About: ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
Employees: 107
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
34% more call options, than puts
Call options by funds: $232K | Put options by funds: $173K
24% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 17
5% more funds holding
Funds holding: 81 [Q1] → 85 (+4) [Q2]
10% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 21
2.79% less ownership
Funds ownership: 28.51% [Q1] → 25.71% (-2.79%) [Q2]
27% less capital invested
Capital invested by funds: $52.3M [Q1] → $38M (-$14.3M) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Lake Street Frank Takkinen 47% 1-year accuracy 9 / 19 met price target | 29%upside $15 | Buy Maintained | 27 Aug 2024 |